Khalid Shah, M.S., Ph.D. | Harvard Stem Cell Institute (HSCI)
The Shah lab seeks to develop and test novel, targeted, cell-based therapies for brain cancers. Successful treatment of brain tumors remains one of the greatest challenges in oncology. The recognition that different cell types that have therapeutic potential, can integrate appropriately throughout the mammalian brain following transplantation ...
Khalid Shah - Google Scholar
Annals of Neurology: Official Journal of the American Neurological … BK Yoo, R Gredler, N Vozhilla, Z Su, D Chen, T Forcier, K Shah, ...
Top Harvard Medical School Neuroscientist Accused of Research ...
2024年2月1日 · Khalid Shah, a prominent neuroscientist at Brigham and Women's Hospital, is accused of falsifying data and plagiarizing images across 21 papers. By Naomi S. Castellon-Perez
Khalid Shah – CSTI Director - Center for Stem Cell and …
Dr. Khalid Shah is the Vice Chair of Research for the Department of Neurosurgery at BWH and a Professor at Harvard Medical School. He directs The Center for Stem and Translational Immunotherapy and also a joint Center of Excellence in Biomedicine.
哈佛医学院顶尖学者21篇论文涉嫌造假，涉及多本知名期刊_京报网
2024年2月14日 · 她发现，美国哈佛医学院顶尖神经科学家哈立德·沙阿（Khalid Shah）涉嫌在21篇论文中数据造假并抄袭图像，其中包括在Nature Communication、PNAS等知名期刊上的论文。
顶尖学者21篇论文涉嫌造假，涉及多本知名期刊 - 科学网
2024年2月14日 · 她发现，美国哈佛医学院顶尖神经科学家哈立德·沙阿（Khalid Shah）涉嫌在21篇论文中数据造假并抄袭图像，其中包括在Nature Communication、PNAS等知名期刊上的论文。 沙阿是哈佛医学院干细胞和转化免疫治疗中心主任、教授，还是布莱根妇女医院神经外科研究副主任，致力于干细胞治疗领域的研究，曾获得过许多癌症相关专业协会的研究奖项。 2023年初，沙阿团队曾在Science子刊发表论文，声称设计了一种将癌细胞转化为抗癌剂、防止癌症复 …
Khalid Shah - Director, Center for Stem Cell and Translational ...
Dr. Khalid Shah is the Vice Chair of Research at Brigham and Women's Hospital (BWH) in Boston, MA. He is also the Director of the Center for Stem Cell and Translational Immunotherapy at BWH and...
- 职位: Vice Chair of Research, …
- 位置: Brigham and Women's Hospital
- 500+ 连接数
Khalid Shah | Harvard Division of Medical Sciences - Harvard …
Our research is based on developing clinically translatable models of both primary, recurrent and metastatic brain tumors, and stem cell based cell surface receptor therapeutics that simultaneously target cell death and proliferation pathways in an effort to eradicate brain tumors.
Khalid Shah - Harvard Brain Science Initiative
Our research is based on developing clinically translatable models of both primary and metastatic brain tumors and stem cell based cell surface receptor targeted therapeutics that simultaneously target cell death and proliferation pathways in an effort to eradicate brain tumors.
Khalid Shah | Harvard Stem Cell Institute (HSCI)
2022年6月15日 · Harvard Stem Cell Institute scientists at Massachusetts General Hospital have devised a new way to use stem cells in the fight against brain cancer. A team led by... Stem cells loaded with cancer-killing herpes virus attack a brain tumor cell. Tumor cells in green. oHSV-loaded stem cells in red. oHSV-infected tumor cells in yellow.